title: Myeloprotective effect of short term prechemotherapy recombinant granulocyte-macrophage colony stimulating factor.
authors.affiliation: Department of Pediatric Oncology, Hacettepe University, Institute of Oncology, Ankara, Turkey.
authors.forename: Canan
authors.initials: C
authors.lastname: Akyüz
authors.forename: Kudret
authors.initials: K
authors.lastname: Cağlar
authors.forename: Ali
authors.initials: A
authors.lastname: Varan
authors.forename: Vedat
authors.initials: V
authors.lastname: Köseoğlu
authors.forename: Hande
authors.initials: H
authors.lastname: Canpinar
authors.forename: Tezer
authors.initials: T
authors.lastname: Kutluk
authors.forename: Münevver
authors.initials: M
authors.lastname: Büyükpamukçu
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D005434:Flow Cytometry; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007279:Injections, Subcutaneous; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*; D011292:Premedication; D011994:Recombinant Proteins; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor